Results 231 to 240 of about 434,223 (377)

Rest‐Activity Rhythms and Cognition in Older Adults With and Without Insomnia

Journal of Sleep Research, EarlyView.
ABSTRACT Insomnia is associated with risk for cognitive deficits. However, the literature assessing cognitive impairments in insomnia is replete with conflicting findings; it is unclear whether individuals with insomnia exhibit impaired cognition or whether specific sleep features consistently predict cognitive performance in insomnia.
Miranda G. Chappel‐Farley, Zhiwei Zhao, Christine W. Johnston, Shuo Chen, Avelino C. Verceles, Valerie E. Rogers, Daniel J. Buysse, Emerson M. Wickwire, Kristine A. Wilckens   +8 more
wiley   +1 more source

Exploring the ubiquitination regulatory network: opening new perspectives for rheumatoid arthritis therapy. [PDF]

Ann Med
Wang F, Liu J, Wen J, Sun Y, He M.
europepmc   +1 more source

L'enquête Morin à Plozévet: Bande F106 face A

, 1965
Ledegen, Gudrun, Hess, Aurélie, Morin, Edgar   +2 more
openalex   +1 more source

Excessive Daytime Sleepiness Should Be Systematically Assessed in Individuals With Insomnia: A Population‐Based Study Employing a Virtual Agent‐Based Digital Tool

Journal of Sleep Research, EarlyView.
In a cohort of 21,590 participants undergoing a 17‐day digital sleep intervention, the ‘sleepy insomniac’ phenotype was highly prevalent and was associated with comorbidities in about half of the cases. Compared to individuals with insomnia without sleepiness, these participants were more likely to experience middle or late insomnia symptoms but showed
Julien Coelho, Florian Pécune, Alex Chanteclair, Christophe Gauld, Etienne de Sevin, Emmanuel d'Incau, Patricia Sagaspe, Tafsir Ka, Hervé Alia, Charles M. Morin, Jean‐Arthur Micoulaud‐Franchi, Pierre Philip   +11 more
wiley   +1 more source

Morin as a Modulator of Hepatic Glucose Fluxes: A Balance Between Antihyperglycemic Potential and Mitochondrial Toxicity. [PDF]

J Biochem Mol Toxicol
Nanami LF, Klosowski EM, Mito MS, Esquissato GNM, Viana GA, Abido ACO, Silva MCD, Mendonça APDS, de Melo GSR, Bueno PSA, Garcia FP, Bidoia DL, Nakamura TU, Nakamura CV, Ishii-Iwamoto EL, Ferro AP, Dos Santos WD, Ferrarese-Filho O, Marchiosi R, Constantin RP.   +19 more
europepmc   +1 more source

Lucid Dreaming: Not Just Awareness, but Agency

Journal of Sleep Research, EarlyView.
ABSTRACT During lucid dreaming (LD), dreamers are aware that they are dreaming and may be able to influence the oneiric content. There has been recent debate about the relative importance of the ability to influence the dream and having agency over the pure awareness of dreaming.
Severin Ableidinger, Luigi De Gennaro, Sergio Mota‐Rolim, Serena Scarpelli, Courtney J. Bolstad, Bjørn Bjorvatn, Colin A. Espie, Yves Dauvilliers, Maria Korman, Anne‐Marie Landtblom, Giuseppe Plazzi, Kentaro Matsui, Juliana Yordanova, Adrijana Koscec Bjelajac, Catia Reis, Frances Chung, Ilona Merikanto, Yun K. Wing, Markku Partinen, Tainá Macêdo, Michael R. Nadorff, Brigitte Holzinger   +21 more
wiley   +1 more source

Engaging Adolescents With Chronic Illness in Patient-Education: The Adolescent's Perception. [PDF]

J Eval Clin Pract
Morin MP, Shah AQ, Pomey MP, Bourque CJ, Grierson L, Mylopoulos M, Bowen F.   +6 more
europepmc   +1 more source

Antitumoral action in vitro of the olive leaf extract (Olea europaea L.) and flavonoids morin, naringin, and rutin in cell lines carcinogenic

, 2014
Wander Lopes Pereira
openalex   +1 more source

The Effect of Deep Brain Stimulation on Sleep and Cognition in Patients With Parkinson's Disease

Journal of Sleep Research, EarlyView.
ABSTRACT Sleep–wake disturbances and cognitive decline are among the most common nonmotor symptoms of Parkinson's disease (PD). Deep brain stimulation (DBS) can successfully alleviate motor symptoms. However, the impact on sleep–wake disturbances and cognitive decline, and their interaction, is yet unclear.
Monique E. H. Valk‐Geuke, Gert J. Geurtsen, Rob M. A. de Bie, Rick Schuurman, Martijn Beudel, Esmée Verwijk   +5 more
wiley   +1 more source

Morin Attenuates Diclofenac-Induced Hepatocellular Death Injury via Nrf2/Ho-1/NQO1, Beclin-1/LC3A/LC3B and p53/Bax/Caspase Signalling Pathways. [PDF]

J Biochem Mol Toxicol
Akaras N, Şimşek H, Gür C, Küçükler S, İleritürk M, Kandemir FM.   +5 more
europepmc   +1 more source